Pricing

STEMLINE THERAPEUTICS INC

0 followers ·
NEW YORK NY
Stemline Therapeutics is based out of New York. Stemline Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing proprietary therapeutics that target cancer stem cells (CSCs) and tumor bulk. It develops StemScreen platform technology consisting of StemScreen-1 and StemScreen-2 for the identification of novel CSC-directed compounds. The company is developing SL-401, a biologic-drug conjugate, which has completed Phase I/II clinical trial for relapsed or refractory acute myeloid leukemia; and SL-701, a synthetic peptide vaccine that has completed two Phase I/II clinical trials for pediatric and adult high-grade gliomas.Whalewisdom has at least 73 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2012-01-17. The notice included securities offered of Debt,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Contact Info

Contact information is taken directly from publicly disclosed SEC filings.

STEMLINE THERAPEUTICS INC
750 LEXINGTON AVENUE
NEW YORK NY    10022

Business Phone: 212-831-1111
SEC SIC CODE:
2834-PHARMACEUTICAL PREPARATIONS

Recent SEC Filings

Filing Date
SC 13G/A 2021-02-12
15-12B 2020-06-22
EFFECT 2020-06-16
EFFECT 2020-06-16
EFFECT 2020-06-16
S-8 POS 2020-06-10
S-8 POS 2020-06-10
S-8 POS 2020-06-10
S-8 POS 2020-06-10
S-8 POS 2020-06-10